• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基质降解金属蛋白酶(MMPs)参与动脉粥样硬化的证据。

Evidence for the Involvement of Matrix-Degrading Metalloproteinases (MMPs) in Atherosclerosis.

作者信息

Brown Bethan A, Williams Helen, George Sarah J

机构信息

School of Clinical Sciences, University of Bristol, Bristol, United Kingdom.

School of Clinical Sciences, University of Bristol, Bristol, United Kingdom.

出版信息

Prog Mol Biol Transl Sci. 2017;147:197-237. doi: 10.1016/bs.pmbts.2017.01.004. Epub 2017 Mar 3.

DOI:10.1016/bs.pmbts.2017.01.004
PMID:28413029
Abstract

Atherosclerosis leads to blockage of arteries, culminating in myocardial infarction, and stroke. The involvement of matrix-degrading metalloproteinases (MMPs) in atherosclerosis is established and many studies have highlighted the importance of various MMPs in this process. MMPs were first implicated in atherosclerosis due to their ability to degrade extracellular matrix components, which can lead to increased plaque instability. However, more recent work has highlighted a multitude of roles for MMPs in addition to breakdown of extracellular matrix proteins. MMPs are now known to be involved in various stages of plaque progression: from initial macrophage infiltration to plaque rupture. This chapter summarizes the development and progression of atherosclerotic plaques and the contribution of MMPs. We provide data from human studies showing the effect of MMP polymorphisms and the expression of MMPs in both the atherosclerotic plaque and within plasma. We also discuss work in animal models of atherosclerosis that show the effect of gain or loss of function of MMPs. Together, the data provided from these studies illustrate that MMPs are ideal targets as both biomarkers and potential drug therapies for atherosclerosis.

摘要

动脉粥样硬化会导致动脉阻塞,最终引发心肌梗死和中风。基质降解金属蛋白酶(MMPs)参与动脉粥样硬化已得到证实,许多研究强调了各种MMPs在这一过程中的重要性。MMPs最初被认为与动脉粥样硬化有关,是因为它们能够降解细胞外基质成分,这可能导致斑块稳定性增加。然而,最近的研究突出了MMPs除了分解细胞外基质蛋白之外的多种作用。现在已知MMPs参与斑块进展的各个阶段:从最初的巨噬细胞浸润到斑块破裂。本章总结了动脉粥样硬化斑块的发展和进展以及MMPs的作用。我们提供了来自人体研究的数据,显示了MMP多态性的影响以及MMPs在动脉粥样硬化斑块和血浆中的表达。我们还讨论了动脉粥样硬化动物模型中的研究工作,这些研究显示了MMPs功能获得或丧失的影响。这些研究提供的数据共同表明,MMPs作为动脉粥样硬化的生物标志物和潜在药物治疗靶点是理想的。

相似文献

1
Evidence for the Involvement of Matrix-Degrading Metalloproteinases (MMPs) in Atherosclerosis.基质降解金属蛋白酶(MMPs)参与动脉粥样硬化的证据。
Prog Mol Biol Transl Sci. 2017;147:197-237. doi: 10.1016/bs.pmbts.2017.01.004. Epub 2017 Mar 3.
2
Multidimensional Contribution of Matrix Metalloproteinases to Atherosclerotic Plaque Vulnerability: Multiple Mechanisms of Inhibition to Promote Stability.基质金属蛋白酶对动脉粥样硬化斑块易损性的多维贡献:促进稳定性的多种抑制机制
J Vasc Res. 2016;53(1-2):1-16. doi: 10.1159/000446703. Epub 2016 Jun 22.
3
Macrophage-mediated proteolytic remodeling of the extracellular matrix in atherosclerosis results in neoepitopes: a potential new class of biochemical markers.巨噬细胞介导的动脉粥样硬化中细胞外基质的蛋白水解重塑产生新表位:一类潜在的新型生化标志物。
Assay Drug Dev Technol. 2010 Oct;8(5):542-52. doi: 10.1089/adt.2009.0258. Epub 2010 Jul 27.
4
Matrix metalloproteinases: influence on smooth muscle cells and atherosclerotic plaque stability.基质金属蛋白酶:对平滑肌细胞和动脉粥样硬化斑块稳定性的影响
Expert Rev Cardiovasc Ther. 2007 Mar;5(2):265-82. doi: 10.1586/14779072.5.2.265.
5
Metalloproteinases promote plaque rupture and myocardial infarction: A persuasive concept waiting for clinical translation.金属蛋白酶促进斑块破裂和心肌梗死:一个有待临床转化的有说服力的概念。
Matrix Biol. 2015 May-Jul;44-46:157-66. doi: 10.1016/j.matbio.2015.01.015. Epub 2015 Jan 28.
6
Therapeutic potential of matrix metalloproteinase inhibitors in atherosclerosis.基质金属蛋白酶抑制剂在动脉粥样硬化中的治疗潜力
Expert Opin Investig Drugs. 2000 May;9(5):993-1007. doi: 10.1517/13543784.9.5.993.
7
[Matrix metalloproteinases and atherosclerosis].[基质金属蛋白酶与动脉粥样硬化]
Postepy Hig Med Dosw (Online). 2011 Jan 25;65:16-27. doi: 10.5604/17322693.931536.
8
Gene expression levels of matrix metalloproteinases in human atherosclerotic plaques and evaluation of radiolabeled inhibitors as imaging agents for plaque vulnerability.人类动脉粥样硬化斑块中基质金属蛋白酶的基因表达水平以及放射性标记抑制剂作为斑块易损性成像剂的评估。
Nucl Med Biol. 2014 Aug;41(7):562-9. doi: 10.1016/j.nucmedbio.2014.04.085. Epub 2014 Apr 21.
9
Matrix metalloproteinases in atherothrombosis.动脉血栓形成中的基质金属蛋白酶。
Prog Cardiovasc Dis. 2010 Mar-Apr;52(5):410-28. doi: 10.1016/j.pcad.2009.12.002.
10
Matrix Metalloproteinases as Biomarkers of Atherosclerotic Plaque Instability.基质金属蛋白酶作为动脉粥样硬化斑块不稳定的生物标志物。
Int J Mol Sci. 2020 May 31;21(11):3946. doi: 10.3390/ijms21113946.

引用本文的文献

1
Prospects and Challenges of Catechins in Cardiovascular Disease.儿茶素在心血管疾病中的前景与挑战
AAPS J. 2025 Jul 14;27(5):119. doi: 10.1208/s12248-025-01105-x.
2
Unraveling LncRNA GAS5 in Atherosclerosis: Mechanistic Insights and Clinical Translation.解析长链非编码RNA GAS5在动脉粥样硬化中的作用:机制洞察与临床转化
Biology (Basel). 2025 Jun 13;14(6):697. doi: 10.3390/biology14060697.
3
Matrix Metalloproteinases: Pathophysiologic Implications and Potential Therapeutic Targets in Cardiovascular Disease.基质金属蛋白酶:心血管疾病中的病理生理意义及潜在治疗靶点
Biomolecules. 2025 Apr 17;15(4):598. doi: 10.3390/biom15040598.
4
Cer(d18:1/16:0) as a biomarkers for acute coronary syndrome in Chinese populations.神经酰胺(Cer(d18:1/16:0))作为中国人群急性冠状动脉综合征的生物标志物
Sci Rep. 2025 Apr 23;15(1):14014. doi: 10.1038/s41598-025-98010-2.
5
Lack of Association of Serum MMP-9 Concentration and rs17576 Single Nucleotide Variant Gene With the Degree of Coronary Atherosclerosis and Other Risk Factors in Ukrainian Patients With Coronary Artery Disease.乌克兰冠心病患者血清基质金属蛋白酶-9浓度及rs17576单核苷酸变异基因与冠状动脉粥样硬化程度及其他危险因素的相关性研究
Cardiol Res Pract. 2025 Feb 23;2025:6610742. doi: 10.1155/crp/6610742. eCollection 2025.
6
Emerging nanoprobes for the features visualization of vulnerable atherosclerotic plaques.用于易损动脉粥样硬化斑块特征可视化的新型纳米探针。
Smart Med. 2024 Dec 3;3(4):e20240033. doi: 10.1002/SMMD.20240033. eCollection 2024 Dec.
7
Nox1/PAK1 is required for angiotensin II-induced vascular inflammation and abdominal aortic aneurysm formation.血管紧张素II诱导的血管炎症和腹主动脉瘤形成需要Nox1/PAK1。
Redox Biol. 2025 Feb;79:103477. doi: 10.1016/j.redox.2024.103477. Epub 2024 Dec 19.
8
Vascular Extracellular Matrix in Atherosclerosis.血管细胞外基质在动脉粥样硬化中的作用
Int J Mol Sci. 2024 Nov 8;25(22):12017. doi: 10.3390/ijms252212017.
9
siLOXL2 Inhibits Endothelial Inflammatory Response and EndMT Induced by ox-LDL.siLOXL2 抑制 ox-LDL 诱导的内皮炎症反应和 EndMT。
Cerebrovasc Dis Extra. 2024;14(1):165-176. doi: 10.1159/000541906. Epub 2024 Oct 17.
10
Syndecan-1 as a predictor of vulnerable atherosclerotic plaques.Syndecan-1作为易损动脉粥样硬化斑块的预测指标。
Front Cell Dev Biol. 2024 Aug 8;12:1415788. doi: 10.3389/fcell.2024.1415788. eCollection 2024.